Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients

BACKGROUND: Coagulopathies are a major class among COVID-19 associated complications. Although anticoagulants such as unfractionated Heparin and Enoxaparin are both being used for therapeutic mitigation of COVID associated coagulopathy (CAC), differences in their clinical outcomes remain to be inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlowski, Colin, Venkatakrishnan, AJ, Kirkup, Christian, Berner, Gabriela, Puranik, Arjun, O'Horo, John C., Badley, Andrew D., Soundararajan, Venky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941023/
https://www.ncbi.nlm.nih.gov/pubmed/33718845
http://dx.doi.org/10.1016/j.eclinm.2021.100774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941023/
https://www.ncbi.nlm.nih.gov/pubmed/33718845
http://dx.doi.org/10.1016/j.eclinm.2021.100774

Ejemplares similares